Impact Factor
2.62
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.76
90 total citations
h5-index
11
h5 depth signal
Cited share
60.8%
31 of 51
Total citations
90
Citation footprint
Metric signal
1.60
External metric anchor
Self-citation
1.1%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
India
87
United States
65
Iran
65
Morocco
28
Italy
26
Citing Fields of Research
Cardiology
141
Hematology
77
Diabetes
55
Phytochemicals
54
Lipids
20
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
667
Articles tracked across the journal lifetime
Indexed publication set
51
31 cited publications
Last 12 months
62
5.6 publications/month
Open access share
4.8%
3 OA publications in the last year
Leading citing country
India
87 citing publications
Leading citing field
Cardiology
141 citing publications
Latest tracked publication
14 October 2026
10 recent records available
Coverage & Indexing History
v6n1, Mar. 2006-
v6n1, Mar. 2006-
Research Focus & Classification
Indexed Subjects
Cardiology
Hematology
Diabetes
Lipids
Phytochemicals
Broad Categories
Cardiology
Drug Therapy
Hematology
Vascular Diseases
Phytochemicals
Urology
Hepatitis
Lipids
MeSH Descriptors
Cardiovascular Agents
Cardiovascular Diseases
Drug Delivery Systems
Hematologic Agents
Hematologic Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.2174/011871529x495679261009064725
Open DOI
Cost-effectiveness of Empagliflozin in Chronic Heart Failure: A Markov Model-based Analysis in Uzbekistan
Introduction: Chronic Heart Failure (CHF) is a major public health challenge associated with high morbidity, mortality, and healthcare costs. Empagliflozin has demonstrated clinical benefits across the spectrum of heart failure; however,...
02
DOI 10.2174/011871529x494489260914114458
Open DOI
Role of Gut Microbiome-derived Trimethylamine N-oxide and Short-chain Fatty Acids in Heart Failure Outcomes: A Narrative Review
Introduction: HF continues to be a serious medical problem all over the world, resulting in significant morbidity and mortality despite advancements in therapeutic strategies. Current research indicates the involvement of the gut-heart a...
03
DOI 10.2174/011871529x480529260812061106
Open DOI
SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Managing Metabolic Syndrome Among Patients with Type 2 Diabetes Mellitus - A Narrative Review
Introduction: Metabolic syndrome (MetS) is a cardiometabolic disorder defined by the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III). It is closely linked with type 2 diabetes mellitus (T2DM). The main fea...
04
DOI 10.2174/011871529x448903260820091109
Open DOI
The Silent Vascular Shift: Endothelial Dysfunction and Cardiovascular Risk in Menopausal Women
Background:: Cardiovascular disease (CVD) is the leading cause of death among women worldwide, with the risk significantly increasing after menopause. Hormonal changes during menopause influence the pathophysiology of endothelial dysfunc...
05
DOI 10.2174/011871529x502187260803101832
Open DOI
Venous Congestion in Metabolic Heart Disease: Potential Indirect Role of Dual Incretin Agonists
Introduction: Venous congestion is responsible for symptoms, organ dysfunction, and negative outcomes in heart failure. In obesity-related Heart Failure (HF) with preserved ejection fraction (HFpEF), metabolic dysfunction, inflammation, ...
06
DOI 10.2174/011871529x437571251214200529
Open DOI
Macrophage Polarization and Endothelial Dysfunction in Response to Cigarette Smoke and Ketone Body Administration
Introduction: Cigarette smoking is a major cardiovascular risk factor that induces endothelial dysfunction through chronic inflammation and macrophage-mediated vascular injury. Macrophages exhibit plasticity by polarizing into pro-inflam...
07
DOI 10.2174/011871529x423173251208100541
Open DOI
Nanotechnology - Driven Innovations in Anticoagulant Delivery and Antidote Development for Hemostasis Regulation
Introduction: Hemostasis is a complex physiological mechanism that maintains normal blood flow and prevents excessive bleeding after vascular injury. Anticoagulant drugs are widely used to prevent systemic embolism, stroke, and recurrent...
08
DOI 10.2174/011871529x414660251209135356
Open DOI
Integrating AI in Cardiovascular Systems: Innovations in Diagnosis, Risk Prediction, and Management
Worldwide, cardiovascular diseases remain the leading contributors to illness and death, which hinders rapid diagnosis and efficient treatment. Recent developments in artificial intelligence (AI) have transformed cardiovascular medicine ...
09
DOI 10.2174/011871529x473049260710110225
Open DOI
Marine Products as Therapeutics for Atherosclerosis Through Modulation of Gut-heart Axis
Introduction: A bidirectional relationship between cardiovascular health and gut microbiota, established by the gut-heart axis, is a major contributor to the development or prevention of atherosclerosis. Chronic immune-inflammatory and f...
10
DOI 10.2174/011871529x488257260710041631
Open DOI
Safety and Efficacy of Ticagrelor with Aspirin DAPT vs. Aspirin Alone in Patients Undergoing CABG Following ACS: A Systematic Review and Meta-Analysis
Background: It remains uncertain whether Dual Antiplatelet Therapy (DAPT) or aspirin alone is better for patients following Coronary Artery Bypass Grafting (CABG) post-Acute Coronary Syndrome (ACS). Currently available Systematic Reviews...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.